Panbela Therapeutics, Inc. Profile Avatar - Palmy Investing

Panbela Therapeutics, Inc.

Panbela Therapeutics, Inc., a clinical-stage biopharmaceutical company, together with its subsidiaries, focuses on developing disruptive therapeutics for the treatment of patients with cancer. The company focuses on diseases of the pancreas, including pa…

Biotechnology
US, Waconia [HQ]

Resulting Ratios

13 Records · Starting from 2011
Loading...
End of PBLA's Analysis
CIK: 1029125 CUSIP: 69833W107 ISIN: US69833W4042 LEI: - UEI: -
Secondary Listings
PBLA has no secondary listings inside our databases.